Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Motoneuron differentiation of induced pluripotent stem cells from SOD1G93A mice.

Yao XL, Ye CH, Liu Q, Wan JB, Zhen J, Xiang AP, Li WQ, Wang Y, Su H, Lu XL.

PLoS One. 2013 May 28;8(5):e64720. doi: 10.1371/journal.pone.0064720. Print 2013. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/2033887d-1abc-48d1-b87f-dc30f75cfa2d.

2.

[Generation of induced pluripotent stem cells from amyotrophic lateral sclerosis patientcarrying SOD1-V14M mutation].

Liu X, Chen J, Li X, Gao S, Deng M.

Zhonghua Yi Xue Za Zhi. 2014 Jul 15;94(27):2143-7. Chinese.

PMID:
25327864
3.

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons.

Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, Croft GF, Saphier G, Leibel R, Goland R, Wichterle H, Henderson CE, Eggan K.

Science. 2008 Aug 29;321(5893):1218-21. doi: 10.1126/science.1158799. Epub 2008 Jul 31.

4.

A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.

Burkhardt MF, Martinez FJ, Wright S, Ramos C, Volfson D, Mason M, Garnes J, Dang V, Lievers J, Shoukat-Mumtaz U, Martinez R, Gai H, Blake R, Vaisberg E, Grskovic M, Johnson C, Irion S, Bright J, Cooper B, Nguyen L, Griswold-Prenner I, Javaherian A.

Mol Cell Neurosci. 2013 Sep;56:355-64. doi: 10.1016/j.mcn.2013.07.007. Epub 2013 Jul 25.

5.

Dysregulation of astrocyte-motoneuron cross-talk in mutant superoxide dismutase 1-related amyotrophic lateral sclerosis.

Ferraiuolo L, Higginbottom A, Heath PR, Barber S, Greenald D, Kirby J, Shaw PJ.

Brain. 2011 Sep;134(Pt 9):2627-41. doi: 10.1093/brain/awr193.

7.
8.

GDNF is trophic for mouse motoneurons that express a mutant superoxide dismutase (SOD-1) gene.

Derby ML, Giuliano R, Figlewicz DA, Bohn MC.

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Mar;1(2):113-22.

PMID:
11467048
9.

SIRT1 overexpression ameliorates a mouse model of SOD1-linked amyotrophic lateral sclerosis via HSF1/HSP70i chaperone system.

Watanabe S, Ageta-Ishihara N, Nagatsu S, Takao K, Komine O, Endo F, Miyakawa T, Misawa H, Takahashi R, Kinoshita M, Yamanaka K.

Mol Brain. 2014 Aug 29;7:62. doi: 10.1186/s13041-014-0062-1.

10.

Transient recovery in a rat model of familial amyotrophic lateral sclerosis after transplantation of motor neurons derived from mouse embryonic stem cells.

López-González R, Kunckles P, Velasco I.

Cell Transplant. 2009;18(10):1171-81. doi: 10.3727/096368909X12483162197123. Epub 2009 Aug 5.

PMID:
19660174
11.

Minimally invasive transplantation of iPSC-derived ALDHhiSSCloVLA4+ neural stem cells effectively improves the phenotype of an amyotrophic lateral sclerosis model.

Nizzardo M, Simone C, Rizzo F, Ruggieri M, Salani S, Riboldi G, Faravelli I, Zanetta C, Bresolin N, Comi GP, Corti S.

Hum Mol Genet. 2014 Jan 15;23(2):342-54. doi: 10.1093/hmg/ddt425. Epub 2013 Sep 4.

12.

A small molecule screen in stem-cell-derived motor neurons identifies a kinase inhibitor as a candidate therapeutic for ALS.

Yang YM, Gupta SK, Kim KJ, Powers BE, Cerqueira A, Wainger BJ, Ngo HD, Rosowski KA, Schein PA, Ackeifi CA, Arvanites AC, Davidow LS, Woolf CJ, Rubin LL.

Cell Stem Cell. 2013 Jun 6;12(6):713-26. doi: 10.1016/j.stem.2013.04.003. Epub 2013 Apr 18.

13.

Fas small interfering RNA reduces motoneuron death in amyotrophic lateral sclerosis mice.

Locatelli F, Corti S, Papadimitriou D, Fortunato F, Del Bo R, Donadoni C, Nizzardo M, Nardini M, Salani S, Ghezzi S, Strazzer S, Bresolin N, Comi GP.

Ann Neurol. 2007 Jul;62(1):81-92.

PMID:
17503505
14.

Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.

Muenthaisong S, Ujhelly O, Polgar Z, Varga E, Ivics Z, Pirity MK, Dinnyes A.

Exp Cell Res. 2012 Nov 15;318(19):2482-9. doi: 10.1016/j.yexcr.2012.07.014. Epub 2012 Jul 28.

PMID:
22846649
15.

Neural progenitors derived from human induced pluripotent stem cells survive and differentiate upon transplantation into a rat model of amyotrophic lateral sclerosis.

Popescu IR, Nicaise C, Liu S, Bisch G, Knippenberg S, Daubie V, Bohl D, Pochet R.

Stem Cells Transl Med. 2013 Mar;2(3):167-74. doi: 10.5966/sctm.2012-0042. Epub 2013 Feb 14.

16.

Wild-type microglia extend survival in PU.1 knockout mice with familial amyotrophic lateral sclerosis.

Beers DR, Henkel JS, Xiao Q, Zhao W, Wang J, Yen AA, Siklos L, McKercher SR, Appel SH.

Proc Natl Acad Sci U S A. 2006 Oct 24;103(43):16021-6. Epub 2006 Oct 16.

17.

Motoneuron subtypes show specificity in glycine receptor channel abnormalities in a transgenic mouse model of amyotrophic lateral sclerosis.

Chang Q, Martin LJ.

Channels (Austin). 2011 Jul-Aug;5(4):299-303. doi: 10.4161/chan.5.4.16206. Epub 2011 Jul 1.

18.
19.

Immunodetection of disease-associated conformers of mutant cu/zn superoxide dismutase 1 selectively expressed in degenerating neurons in amyotrophic lateral sclerosis.

Sábado J, Casanovas A, Hernández S, Piedrafita L, Hereu M, Esquerda JE.

J Neuropathol Exp Neurol. 2013 Jul;72(7):646-61. doi: 10.1097/NEN.0b013e318297fd10.

PMID:
23771221
20.

[ALS disease modeling and drug screening using patient-specific iPS cells].

Egawa N, Inoue H.

Rinsho Shinkeigaku. 2013;53(11):1020-2. Review. Japanese.

PMID:
24291866

Supplemental Content

Support Center